Newsfeeds - Spark Newswire

1 minute read

Analyst Ratings
Biotech
General
Health Care
News
Price Target

Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race

Today, 2:35 PM

Guggenheim Partners initiated coverage on Structure Therapeutics Inc (NASDAQ:GPCR) with a Buy rating and a price target of $50 based on the multi-billion-dollar…

GPCR

1 minute read

Analyst Ratings
Initiation
News
Price Target

BMO Capital Initiates Coverage On Structure Therapeutics with Outperform Rating, Announces Price Target of $40

By Benzinga Newsdesk

Today, 2:35 PM

BMO Capital analyst Evan Seigerman initiates coverage on Structure Therapeutics (NASDAQ:GPCR) with a Outperform rating and announces Price Target of $40.

GPCR

2 minute read

Commodities
Earnings
Eurozone
Global
Intraday Update
Markets
News

Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January

By Lisa Levin

Today, 2:35 PM

U.S. stocks traded lower, with the Dow Jones dropping over 150 points on Friday. The Dow traded down 0.51% to 33,881.69 while the NASDAQ fell 1.32% to 12,039.79. The S&P 500 also fell, dropping, 0.98% to 4,138.89.

BBAI

Latest news

Analysts Sees Over 50% Upside Opportunity For This Newly Listed Obesity Player Stock, Participating In Big Pharma Race

BMO Capital Initiates Coverage On Structure Therapeutics with Outperform Rating, Announces Price Target of $40

Dow Drops Over 150 Points; US economy Adds 517,000 Jobs In January